• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » First U.S. facilities adopt Memic Innovative Surgery’s Hominis robotic surgery platform

First U.S. facilities adopt Memic Innovative Surgery’s Hominis robotic surgery platform

January 6, 2022 By Sean Whooley

Memic Hominy
[Image from Memic]
Memic Innovative Surgery announced today that three U.S.-based facilities acquired the Hominis robot-assisted surgical system.

HCA Florida Healthcare’s Kendall Regional Medical Center, Advent Health Celebration and The Women’s Hospital at Jackson Memorial all acquired the Hominis surgical system.

Tel Aviv, Israel-based Memic’s Hominis system will now be used at the facilities in single-site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures including benign hysterectomy, according to a news release. The company touts Hominis as the first and only FDA-authorized surgical robot with miniature humanoid-shaped arms with shoulder, elbow and wrist joints that provide human-level dexterity and 360-degree articulation.

Memic — which confirmed its plans to go public in a SPAC merger in August 2021 — designed the Hominis system to replicate the motions and capabilities of a surgeon’s arms, requiring a smaller footprint with lower costs than conventional robotic systems, the company said.

Hominis received FDA de novo clearance in February 2021.

“We are proud to partner with these leading healthcare providers to empower surgeons with a better user experience and help them better serve the thousands of women who undergo gynecologic surgery each year,” Memic Co-Founder & CEO Dvir Cohen said in the release. “These sites establish a strong foundation for expanding market adoption of Hominis, including a leading robotic surgery center of excellence, a 450-bed hospital owned by one of the largest U.S. hospital systems, and a 1,550-bed nonprofit teaching hospital affiliated with an acclaimed medical school.

“With their support, we are expanding our commercial footprint to increase the reach of our proprietary technology and have a positive impact on the Florida region and elsewhere as we work to expand adoption of Hominis worldwide.”

Filed Under: Business/Financial News, Featured, News Well, Surgical, Surgical Robotics Tagged With: Memic Innovative Surgery, robot-assisted, Robotic Surgery

More recent news

  • Cooper Companies continues to see activist pressure to sell divisions, replace CEO
  • Cordis earns FDA nod for Selution SLR drug-eluting balloon
  • Siemens Healthineers links with Novo to advance liver fibrosis blood test
  • GE HealthCare rolls out AI software for predicting care bottlenecks
  • Wandercraft’s self-balancing Eve exoskeleton begins US launch

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy